Collegium Pharmaceutical, Inc. (COLL)
Chart Events
Performance Outlook
| Previous Close | 19.56 |
| Open | 19.30 |
| Bid | 17.83 x 1100 |
| Ask | 20.65 x 1200 |
| Day's Range | 18.92 - 19.64 |
| 52 Week Range | 17.57 - 26.91 |
| Volume | |
| Avg. Volume | 273,987 |
| Market Cap | 671.467M |
| Beta (5Y Monthly) | 0.89 |
| PE Ratio (TTM) | 16.17 |
| EPS (TTM) | 1.18 |
| Earnings Date | May 06, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 26.71 |
- American City Business Journals
These 40 Mass. companies made the new Deloitte Fast 500 list
The list, released Wednesday, ranks the fastest-growing technology, media, telecommunications and life sciences companies based in North America.
- GlobeNewswire
Collegium Announces $25 Million Accelerated Share Repurchase Program
STOUGHTON, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that it has entered into an Accelerated Share Repurchase ("ASR") agreement with Jefferies LLC to repurchase $25 million of the Company’s common stock. Collegium will execute the ASR as part of the $100 million share repurchase program authorized by its Board of Directors in August 2021.
- GlobeNewswire
UPDATE: Collegium to Participate in Upcoming Conferences
STOUGHTON, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences: Jefferies London Healthcare ConferenceVirtual one-on-one meetingsDate: Thursday, November 18, 2021 Piper Sandler Annual Healthcare Conference 2021Virtual fireside chatDate: Wednesday, December 1, 2021 The fireside ch
